The eyesON Big Pharma M&As: Clinical Trials Data Visualization allows you to explore the consequences of some of the biggest mergers and acquisitions (M&As) in the pharmaceutical industry.
This interactive clinical trials data visualization app offers an immersive insights into the impact of mergers and acquisitions (M&As) on the pharmaceutical industry. Users can explore the effects of some of the biggest M&As in pharma industry from 2000 onward, by examining how these events affect number of ran clinical trials, R&D spending, and share prices of some of the biggest pharma sponsor companies out there.
Through this app, users can gain valuable insights into how M&As shape the industry, which can enable them to make informed strategic decisions based on data-driven analysis.
Data
The basis for the Big Pharma M&As: Clinical Trials Data Visualization is the data collected from ClinicalTrials.gov, finance.yahoo.com, and sec.gov databases between 2000 and 2022, ensuring up-to-date clinical trial trends information.
Detailed information about the data used, methods of data extraction and statistical considerations used in the analysis, you can find in the Data Definition tab of the app.
eyesON series
Big Pharma M&As: Clinical Trials Data Visualization is just one of the visualizers in Cyntegrity’s eyesON series of interactive data visualizers. We envision this series as a way our company can give back to the clinical research community. By utilizing our data processing skills and clinical research expertise, we try to come up with useful data visualization tool that our industry peers can freely use to conveniently access the clinical industry insights.
Interested in other Cyntegrity interactive data visualizers? Check them out here.
Our Commitment to Innovation and Personal Growth
We are dedicated to providing innovative solutions that help our clients make the most of their data. One of our latest offerings is the Cyntegrity eyesON apps, which provide visual aids to help users efficiently and effectively understand the significance of data. The development of these apps brings cross-functional team members together, and it serves as an exercise to challenge our internal talents and drive personal growth.
We believe in continuous improvement, and commit to fostering an environment where our team members can develop new skills and grow both professionally and personally. These projects are a crucial part of our strategy for investing in our human capital, and we are proud of the results we have achieved so far.
